INGRAM DOUGLAS S
SEC insider (Form 3/4/5 filer). CIK 0001190644. Director at Relay Therapeutics, Inc. (RLAY) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in CAMBRIDGE, MA.
Companies INGRAM DOUGLAS S has filed insider reports for
- Relay Therapeutics, Inc. (RLAY): Director
- ARROWHEAD PHARMACEUTICALS, INC. (ARWR): Director
- Sarepta Therapeutics, Inc. (SRPT): Director, Officer, Chief Executive Officer
INGRAM DOUGLAS S
CIK: 0001190644
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 9, 2026RLAY
Relay Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32.9K shares- - Dec 16, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AwardDirect7.8K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect73K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect96.5K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect50K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect269.5K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect50K shares- - Jun 6, 2025RLAY
Relay Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
136.7K shares- - Feb 6, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AwardDirect38.4K shares at avg. $20.09$771K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | RLAY Relay Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,947 | - | - | Direct |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award | 7,819 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 73,001 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 96,541 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 50,000 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 269,542 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 50,000 | - | - | Direct |
| Jun 6, 2025 | RLAY Relay Therapeutics, Inc. | Award Stock Option (Right to Buy) | 136,681 | - | - | Direct |
| Feb 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award | 38,396 | $20.09 | $771,376 | Direct |
1-9 of 9 transactions